Clinical trials
Phase 1/2 Glioma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AHS Cancer Control Alberta | 1 |
| Amgen | 1 |
| Blueprint Medicines Corporation | 1 |
| Celgene | 1 |
| Eisai Inc. | 1 |
| Hoffmann-La Roche | 1 |
| National Cancer Institute (NCI) | 1 |
| Novartis Pharmaceuticals | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Turning Point Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 10 |
| Glioblastoma | 4 |
| Recurrence | 4 |
| Central Nervous System Neoplasms | 3 |
| Brain Neoplasms | 2 |
| Medulloblastoma | 2 |
| Neoplasm Metastasis | 2 |
| Neuroblastoma | 2 |
| Rhabdomyosarcoma | 2 |
| Sarcoma | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.